Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Breast Cancer Metastatic × Paclitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 228 Carcinoma, Non-Small-Cell Lung 189 Ovarian Neoplasms 115 Lung Neoplasms 94 Esophageal Neoplasms 62 Triple Negative Breast Neoplasms 56 Stomach Neoplasms 52 Squamous Cell Carcinoma of Head and Neck 49 Neoplasm Metastasis 45 Fallopian Tube Neoplasms 44 Head and Neck Neoplasms 41 Carcinoma, Ovarian Epithelial 39 Esophageal Squamous Cell Carcinoma 37 Neoplasms 31 Endometrial Neoplasms 31 Recurrence 27 Uterine Cervical Neoplasms 25 Adenocarcinoma Of Esophagus 23 Adenocarcinoma of Lung 21 Urinary Bladder Neoplasms 20 Carcinoma, Squamous Cell 18 Melanoma 17 Prostatic Neoplasms 16 Small Cell Lung Carcinoma 15 Carcinoma 15 Breast Neoplasms, Male 14 Adenocarcinoma, Bronchiolo-Alveolar 12 Peritoneal Neoplasms 10 Inflammatory Breast Neoplasms 10 Testicular Neoplasms 9

Interventions

Fulvestrant 5 Letrozole 3 ribociclib 2 exemestane 2 dalpiciclib 2 apatinib 2 Gemcitabine 2 Capecitabine 2 Anastrozole 2 tusamitamab ravtansine 1 trastuzumab deruxtecan 1 palbociclib 1 margetuximab 1 irinotecan sucrosofate 1 fluzoparib 1 abemaciclib 1 Vinorelbine 1 Trastuzumab 1 Tamoxifen 1 Paclitaxel 1 Liposomes 1 Irinotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04603183 2025-12-12

ABIGAIL

MedSIR

Phase 2 Completed

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡